Umecrine Cognition is developing a completely new type of drug for neurological disorders in the brain that can occur as a result of a number of underlying diseases and lead to severely reduced cognition and alertness.
The results from an internationally recognized clinical phase 2 study indicate that the company’s most advanced drug candidate, golexanolone, improves brain signaling and cognition and alertness in patients with hepatic encephalopathy.
The continued development of golexanolone is initially focused on patient groups whose symptoms have arisen as a result of chronic liver diseases, but the mechanism of action is also relevant in a number of other indication areas.
The results from an internationally recognized clinical phase 2 study indicate that the company’s most advanced drug candidate, golexanolone, improves brain signaling and cognition and alertness in patients with hepatic encephalopathy.
The continued development of golexanolone is initially focused on patient groups whose symptoms have arisen as a result of chronic liver diseases, but the mechanism of action is also relevant in a number of other indication areas.
Company Details
- Employees
- 12
- Founded
- -
- Address
- Nanna Svartz Väg 6a (Floor 4), Karolinska Institutet Science Park,sweden
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.umecrinecognition.com
- Keywords
- pbc, biotech, cognitive disorders, drug development, neurological disorders, hepatic encephalopathy, primary biliary cholangitis, fatigue, golexanolone, cognitive function, parkinsons disease, GABAA receptor.
- HQ
- Solna, Stockholm County
Umecrine Cognition Ab Questions
Umecrine Cognition Ab's website is http://www.umecrinecognition.com
Umecrine Cognition Ab's LinkedIn profile is https://se.linkedin.com/company/umecrine-cognition-ab
Umecrine Cognition Ab has
12 employees.
View email and phone details for 12
employees at Umecrine Cognition Ab.
Umecrine Cognition Ab's industry is
Biotechnology Research
Umecrine Cognition Ab's top competitors are
Inify Laboratories,
Alba Health,
H100,
Xbrane Biopharma Ab,
Aureal One,
Emp Metals Corp,
Tirmed Pharma,
Chosa Oncology,
Cereno Scientific,
Spermosens Ab.
Umecrine Cognition Ab's categories are Biotechnology Research
Umecrine Cognition Ab's founding year is 2000
